LINC01435: A Long Intergenic Non-Protein Coding RNA as a Drug Target or Biomarker

Target Name: LINC01435

NCBI ID: G103695365

LINC01435

Other Name(s): long intergenic non-protein coding RNA 1435 | Long intergenic non-protein coding RNA 1435 | TCONS_00018040

LINC01435: A Long Intergenic Non-Protein Coding RNA as a Drug Target or Biomarker

Introduction

LINC01435 is a long non-coding RNA (lncRNA) that has been identified in various organisms, including humans. It is characterized by its ability to interact with proteins and other non-protein molecules, as well as its involvement in various cellular processes. In In recent years, the characterization of lncRNAs has led to a growing interest in their potential as drug targets or biomarkers. In this article, we will explore the potential of LINC01435 as a drug target or biomarker.

Drug Target Potential

The potential of LINC01435 as a drug target is based on its various interacts with protein targets. LncRNAs have been shown to play important roles in protein-protein interactions, which are critical for cellular signaling and function. LINC01435 has been shown to interact with various proteins , including the protein known as SMN1.

SMN1 is a protein that is essential for the survival of spinal muscular atrophy (SMA) patients. SMA is a genetic disorder that affects muscle strength and function, and is caused by a deficiency of dystrophin. Dystrophin is a protein that helps maintain muscle strength and function, and is missing in SMA patients. LINC01435 has been shown to promote the expression of SMN1, which could potentially lead to increased levels of SMN1 and improved muscle strength and function in SMA patients.

Another potential drug target for LINC01435 is its involvement in the regulation of cellular processes that are important for cancer progression. LncRNAs have been shown to play important roles in the regulation of cell cycle progression, apoptosis, and angiogenesis, which are all critical for cancer growth and progression.

Biomarker Potential

In addition to its potential as a drug target, LINC01435 may also be a valuable biomarker for various diseases. For example, LINC01435 has been shown to be involved in the regulation of stem cell proliferation and differentiation. This suggests that LINC01435 may be a useful biomarker for diseases that involve stem cell dysfunction, such as cancer.

LINC01435 has also been shown to be involved in the regulation of inflammation and immune responses. This suggests that LINC01435 may be a useful biomarker for diseases that involve inflammation or immune dysfunction.

Conclusion

In conclusion, LINC01435 is a long non-coding RNA that has been shown to interact with various proteins and play important roles in cellular processes. Its potential as a drug target or biomarker is based on its ability to interact with protein targets and its involvement in various cellular processes. Further research is needed to fully understand the potential of LINC01435 as a drug target or biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 1435

The "LINC01435 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01435 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets